Literature DB >> 10431843

Invariant chain expression in colon neoplasms.

Z Jiang1, M Xu, L Savas, P LeClair, B F Banner.   

Abstract

Invariant chain (Ii) is a chaperone molecule that inhibits binding of endogenous antigens to class II molecules. High levels of Ii in cancer cells may prevent tumour antigen expression with class II and render the tumour less immunogenic. To correlate the expression of Ii and class II molecules in colon carcinomas with the density of tumour infiltrating lymphocytes (TILs), surgical specimens from a total of 48 patients with well-(WDAC), moderately (MDAC) and poorly differentiated adenocarcinomas (PDAC), adenoma with high-grade dysplasia (AdHGD) and adenomas were immunostained for Ii and class II antigen (HLA-DR). Aggregates of TILs were graded in H&E-stained sections. Normal colon epithelium was negative for Ii and HLA-DR. Invasive carcinomas showed a linear increase in the expression of Ii in the progression from low- to high-grade tumours, while there was no significant difference in HLA-DR expression across the groups. Invasive carcinomas showed a disproportionate increase in Ii over HLA-DR. Frequency of TILs showed inverse correlation with expression of Ii and tumour grade. This is the first demonstration that expression of Ii increases in the progression from low- to high-grade colon neoplasms and is most marked in the poorly differentiated carcinomas. Ii expression by carcinomas is inversely related to the frequency of TILs. The findings suggest that increased Ii renders the tumour less immunogenic and less likely to stimulate a host immune response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431843     DOI: 10.1007/s004280050391

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  Identification of differentially expressed genes in normal mucosa, adenoma and adenocarcinoma of colon by SSH.

Authors:  M J Luo; M D Lai
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  CD74 is a survival receptor on colon epithelial cells.

Authors:  Nitsan Maharshak; Sivan Cohen; Frida Lantner; Gili Hart; Lin Leng; Richard Bucala; Idit Shachar
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

3.  Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.

Authors:  David V Gold; Rhona Stein; Jack Burton; David M Goldenberg
Journal:  Int J Clin Exp Pathol       Date:  2010-11-23

4.  Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.

Authors:  Xuede Lin; Xiaojian Wang; Haley L Capek; Laura C Simone; Amit Tuli; Chantey R Morris; Adrian J Reber; Joyce C Solheim
Journal:  Cancer Immunol Immunother       Date:  2008-10-01       Impact factor: 6.968

5.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

Review 6.  Association of intracellular proteins with folded major histocompatibility complex class I molecules.

Authors:  Chantey R Morris; Adrian J Reber; Jason L Petersen; Shanna E Vargas; Joyce C Solheim
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 7.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 8.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

9.  Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease.

Authors:  Fengping Peng; Siyang Yan; Hui Liu; Zhaoyun Liu; Fengjuan Jiang; Panpan Cao; Rong Fu
Journal:  J Investig Med       Date:  2022-02-10       Impact factor: 3.235

10.  Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levels.

Authors:  Peng Wang; Qiao Shi; Teng Zuo; Xiaobo He; Jia Yu; Weixing Wang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.